Lantern Pharma Inc (NAS:LTRN)
$ 3.81 0.05 (1.33%) Market Cap: 41.01 Mil Enterprise Value: 7.43 Mil PE Ratio: 0 PB Ratio: 1.32 GF Score: 39/100

Lantern Pharma Inc at Lytham Partners Spring Investor Conference (Virtual) Transcript

May 18, 2023 / 01:00PM GMT
Release Date Price: $4.7 (-4.08%)
Robert Blum
Lytham Partners, LLC - Analyst

All right. Hello, everyone, and thank you all for joining us during the Lytham Partners Spring 2023 Investor Conference. My name is Robert Blum, Managing Partner of Lytham Partners. During this fireside chat, we welcome Lantern Pharma, ticker symbol of LTRN on the Nasdaq, and their CEO, Panna Sharma.

We'll dive into questions in just a moment. But one final reminder, I want to make sure that the management is available for one-on-one meetings later today. If you've not already signed up and would like to do so, you can send me an e-mail, that's Blum, B-L-U-M at lythampartners.com, or you can visit our website, lythampartners.com/virtual, click on the one-on-one meeting request button, and I will look to get you taken care of.

So with that, I will go ahead and get started. So welcome, Panna.

Panna Sharma
Lantern Pharma Inc. - CEO, President & Director

Thank you, Robert. Good to be here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot